Steven D. Harr
Overview
Steven D. Harr received an average of $4M in total compensation, including $613K in salary, at Sana Biotechnology from 2020 to 2023. Steven Harr also received an average of $3M at Juno Therapeutics from 2014 to 2016.
- 2023
- 2022
- 2021
- 2020
- 2016
- 2015
- 2014
Sana BiotechnologyPresident, Chief Executive Officer, and Director
Sana BiotechnologyPresident, Chief Executive Officer, and Director
Sana BiotechnologyPresident, Chief Executive Officer, and Director
Sana BiotechnologyPresident, Chief Executive Officer, and Director
Juno TherapeuticsChief Financial Officer and Head of Corporate Development
Juno TherapeuticsChief Financial Officer and Head of Corporate Development
Juno TherapeuticsChief Financial Officer and Head of Corporate Development
Source: SEC filings on April 26, 2024, April 28, 2023, April 26, 2022, and April 21, 2017.
Related executives
We found eight more executives who work or worked at Sana Biotechnology and Juno Therapeutics.
Douglas Williams
Sana Biotechnology
Former Executive Vice President and President, Research and Development
Nathan Hardy
Sana Biotechnology
Chief Financial Officer
Bernard Cassidy
Sana Biotechnology
General Counsel
Sunil Agarwal
Sana Biotechnology
Chief Medical Officer
Hans Bishop
Juno Therapeutics
Chief Executive Officer
Hyam Levitsky
Juno Therapeutics
Chief Scientific Officer
Robert Azelby
Juno Therapeutics
Executive Vice President, Chief Commercial Officer
Mark Frohlich
Juno Therapeutics
Executive Vice President, Portfolio Strategy
News
Sana Biotechnology Former Executive Vice President and President, Research and Development Douglas Williams receives $3M in 2023
April 26, 2024
Sana Biotechnology General Counsel Bernard Cassidy receives $4M in 2022
April 28, 2023
Sana Biotechnology Chief Medical Officer Sunil Agarwal receives $1.9M in 2021
April 26, 2022